IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: Stage-dependent increase in mycosis fungoides progression

Experimental Dermatology

Volumn 9, Issue 4, 2000, Pages 248-251

  Asadullah, K ^a,b   Haeussler Quade A ^a   Gellrich, S ^a   Hanneken, S ^a   Hansen Hagge, T E ^a   Docke W D ^a   Volk, H D ^a   Sterry, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Cutaneous lymphomas; Cytokines; IL 15; IL 16; Mycosis fungoides

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 16; MESSENGER RNA;

ARTICLE; CELL LINE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MYCOSIS FUNGOIDES; PSORIASIS; SKIN INFILTRATE; SKIN LYMPHOMA; T CELL LYMPHOMA;

ADULT; ANTIGENS, CD30; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; GENE EXPRESSION; HUMANS; INTERLEUKIN-15; INTERLEUKIN-16; LYMPHOMA, T-CELL, CUTANEOUS; MYCOSIS FUNGOIDES; PSORIASIS; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS;

EID: 17144433339     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009004248.x     Document Type: Article

References (10)

1. Asadullah K, Döcke W D, Volk H D, Sterry W. Cytokines and cutaneous T-cell lymphomas. Exp Dermatol 1998: 7 314-320.
2. Döbbeling U, Dummer R, Laine E, Potoczna N, Qin J Z, Burg G. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 1998: 92: 252-258.
3. Center D M, Kornfeld H, Cruikshank W W. Interleukin-16. Int J Biochem Cell Biol 1998: 29: 1231-1234.
4. Center D M, Kornfeld H, Cruikshank W W. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996: 10: 476-481.
5. Sterry W. Mycosis fungoides. Curr Top Pathol 1985: 74: 167-223.
6. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997: 90: 354-371.
7. Boehncke W H, Gerdes J, Wiese M, Kaltoft K. Sterry W. A majority of proliferating T cells in cutaneous malignant T cell lymphomas may lack the high affinity IL-2 receptor (CD25). Arch Dermatol Res 1993: 285: 127-130.
8. Asadullah K, Döcke W D, Haeußler A, Sterry W, Volk H D. Progression of Mycosis fungoides is associated with increasing cutaneous expression of IL-10 mRNA. J Invest Dermatol 1996: 107: 833-837.
9. + cell-specific chemoat-tractant IL-16 in cutaneous T-cell lymphoma. Congress volume of the EORTC - cutaneous lymphoma project group meeting, Vienna, Austria, 1998, p33 (abstract).
10. Bulfone-Paus S, Ungureanu D, Pohl T et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997: 3: 1124-1128.